Independent reporting and analysis across technology, science, startups and invention.
Blue Origin is expanding factories, payload facilities, launch pads and recovery capacity in Florida to support multiple New Glenn flights per week by 2030. The infrastructure plan is substantial, but the rocket must first return safely from a year-long grounding.
Read story
Beijing has proposed prohibitions or licensing controls for 40 AI, biotech and solar technologies while imposing immediate registration on covered transfers. APIs and most public-domain technology remain outside the planned restrictions.
Read story
Anthropic says an internal Claude model reconstructed how key NIST elliptic-curve seeds were generated: a common C-library random-number generator started from Unix timestamps. The result is reproducible, but it is not a break of ECDSA.
Read story
A Florida jury found that Comcast’s X1 platform infringed claim 1 of WhereverTV’s interactive-program-guide patent and awarded a $213 million reasonable royalty. Comcast disputes the result and says it will pursue an appeal.
Read story
CERN and Mistral intend to train a single model on billions of simulated proton collisions to support reconstruction, particle identification and anomaly detection. The project is ambitious, but no model, benchmark, budget or delivery date has yet been released.
Read story
Shenzhen startup DexForce is training humanoid robots in simulation before transferring policies to physical machines. Its new UNITAS preprint gives the strategy a technical core, but the headline benchmark results remain company-authored and under review.
Read story
OpenAI alleges a former employee sent more than 100 confidential files about an unreleased device to personal accounts and later briefed Apple leaders. Apple says it has found no supporting evidence, while a federal judge has ordered limited fast-track discovery in Apple’s original trade-secret case.
Read story
A global settlement ends six patent, trade-secret, contract and antitrust disputes. Liquidia can keep selling Yutrepia for PAH, but it must remove PH-ILD from the label, curb promotion, end trial cohorts and make net payments of $380.7 million.
Read story
A sensor-and-actuator lattice reported in Nature turns initially scattered vibrations into one stable collective rhythm. The laboratory result reveals a new form of wave coarsening, but it is not yet a self-directing robot or a deployable material.
Read story